ЕРИТРОПОЕТИН ЯК НЕЗАЛЕЖНИЙ ПРОГНОСТИЧНИЙ ФАКТОР У ХВОРИХ НА МІЄЛОДИСПЛАСТИЧНІ СИНДРОМИ
Aim: To assess the level of erythropoietin (EPO) in blood sera of patients with different subtypes of myelodysplastic syndromes (MDS) from different risk subgroups and to determine its prognostic role. Materials and Methods: EPO was measured by enzyme-linked immunosorbent assay in peripheral blood o...
Saved in:
| Date: | 2023 |
|---|---|
| Main Authors: | , , , , , |
| Format: | Article |
| Language: | English |
| Published: |
PH Akademperiodyka
2023
|
| Subjects: | |
| Online Access: | https://exp-oncology.com.ua/index.php/Exp/article/view/2021-1-11 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Journal Title: | Experimental Oncology |